European Medicines Agency to relocate to Amsterdam
The European Medicines Agency, which has been based in London since its establishment in 1995, will move to Amsterdam, the Netherlands. The need to relocate is a consequence of the U.K.’s withdrawal from the European Union.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
Blog
European Medicines Agency publishes Brexit guidance for pharma companies
The European Medicines Agency has published additional guidance for pharmaceutical companies to help them prepare for the United Kingdom’s withdrawal from the European Union.
-
ArticleVenezuela military intervention highlights critical resources as a new compliance hotspot
President Donald Trump’s military intervention in Venezuela has sent a message across the world that he regards resources as critical to U.S. national security and will act to secure them. In Venezuela, this primarily means crude oil reserves. However, oil is not the only valuable resource in the U.S. sights.
-
OpinionExperts outline core skills compliance teams need to develop in 2026
Compliance teams will face a range of ongoing challenges in the coming year, as well as greater demands from boards and management for better, wider, and more real-time assurance on an increasing range of risk topics.